Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
出版年份 2023 全文链接
标题
Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 12, Pages 10273
出版商
MDPI AG
发表日期
2023-06-19
DOI
10.3390/ijms241210273
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
- (2023) Marko Kumric et al. BIOMEDICINE & PHARMACOTHERAPY
- Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study
- (2023) Ana Batinic et al. Pharmaceuticals
- Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
- (2022) Danielle McCartney et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
- (2022) Robert B. Child et al. Nutrients
- Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
- (2022) Marko Kumric et al. Journal of Personalized Medicine
- Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
- (2022) Justin Matheson et al. Biomolecules
- Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
- (2021) Manuela Contin et al. Frontiers in Pharmacology
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
- (2021) Brittney H. Davis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions
- (2021) Shamema Nasrin et al. DRUG METABOLISM AND DISPOSITION
- Sex differences in medical cannabis-related adverse effects
- (2021) Joshua Aviram et al. PAIN
- The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
- (2021) Samuel Vaughn et al. Journal of Personalized Medicine
- Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
- (2021) Thomas R. Arkell et al. ADDICTION BIOLOGY
- Cannabis and Driving
- (2021) Godfrey D. Pearlson et al. Frontiers in Psychiatry
- The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
- (2020) Valentina Franco et al. CLINICAL PHARMACOKINETICS
- Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase 1 Clinical Trial
- (2020) Paul B. Watkins et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Towards Better Delivery of Cannabidiol (CBD)
- (2020) Sophie Anne Millar et al. Pharmaceuticals
- Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
- (2020) Ana Pilar Pérez-Acevedo et al. Pharmaceuticals
- Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study
- (2019) Alexander Patrician et al. ADVANCES IN THERAPY
- A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
- (2019) Katharina Knaub et al. MOLECULES
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age and sex variation in serum albumin concentration: an observational study
- (2016) Gary Weaving et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PharmGKB summary
- (2011) Stuart A. Scott et al. Pharmacogenetics and Genomics
- How important are sex differences in cannabinoid action?
- (2010) Liana Fattore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interindividual Variation in the Pharmacokinetics of Δ9-Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9
- (2008) C Sachse-Seeboth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now